117 related articles for article (PubMed ID: 7558233)
21. Nerve growth factor decreases soluble guanylate cyclase in rat pheochromocytoma PC12 cells.
Liu H; Force T; Bloch KD
J Biol Chem; 1997 Feb; 272(9):6038-43. PubMed ID: 9038227
[TBL] [Abstract][Full Text] [Related]
22. Interleukin 1 activates soluble guanylate cyclase in human vascular smooth muscle cells through a novel nitric oxide-independent pathway.
Beasley D; McGuiggin M
J Exp Med; 1994 Jan; 179(1):71-80. PubMed ID: 7505803
[TBL] [Abstract][Full Text] [Related]
23. Tirofiban increases soluble guanylate cyclase in rat vascular walls: pharmacological and pathophysiological consequences.
Ruiz-Torres MP; Griera M; Chamorro A; Díez-Marqués ML; Rodríguez-Puyol D; Rodríguez-Puyol M
Cardiovasc Res; 2009 Apr; 82(1):125-32. PubMed ID: 19126601
[TBL] [Abstract][Full Text] [Related]
24. Increased nitrovasodilator sensitivity in endothelial nitric oxide synthase knockout mice: role of soluble guanylyl cyclase.
Brandes RP; Kim D; Schmitz-Winnenthal FH; Amidi M; Gödecke A; Mülsch A; Busse R
Hypertension; 2000 Jan; 35(1 Pt 2):231-6. PubMed ID: 10642303
[TBL] [Abstract][Full Text] [Related]
25. Effect of YC-1, an NO-independent, superoxide-sensitive stimulator of soluble guanylyl cyclase, on smooth muscle responsiveness to nitrovasodilators.
Mülsch A; Bauersachs J; Schäfer A; Stasch JP; Kast R; Busse R
Br J Pharmacol; 1997 Feb; 120(4):681-9. PubMed ID: 9051308
[TBL] [Abstract][Full Text] [Related]
26. Effects of cyclic GMP elevation on isoprenaline-induced increase in cyclic AMP and relaxation in rat aortic smooth muscle: role of phosphodiesterase 3.
Delpy E; Coste H; Gouville AC
Br J Pharmacol; 1996 Oct; 119(3):471-8. PubMed ID: 8894166
[TBL] [Abstract][Full Text] [Related]
27. Soluble guanylate cyclase alpha(1) and beta(1) gene transfer increases NO responsiveness and reduces neointima formation after balloon injury in rats via antiproliferative and antimigratory effects.
Sinnaeve P; Chiche JD; Nong Z; Varenne O; Van Pelt N; Gillijns H; Collen D; Bloch KD; Janssens S
Circ Res; 2001 Jan; 88(1):103-9. PubMed ID: 11139481
[TBL] [Abstract][Full Text] [Related]
28. Soluble guanylyl cyclase expression is reduced in LPS-induced lung injury.
Glynos C; Kotanidou A; Orfanos SE; Zhou Z; Simoes DC; Magkou C; Roussos C; Papapetropoulos A
Am J Physiol Regul Integr Comp Physiol; 2007 Apr; 292(4):R1448-55. PubMed ID: 17204594
[TBL] [Abstract][Full Text] [Related]
29. Effects of the soluble guanylyl cyclase activator, YC-1, on vascular tone, cyclic GMP levels and phosphodiesterase activity.
Galle J; Zabel U; Hübner U; Hatzelmann A; Wagner B; Wanner C; Schmidt HH
Br J Pharmacol; 1999 May; 127(1):195-203. PubMed ID: 10369473
[TBL] [Abstract][Full Text] [Related]
30. Pulmonary soluble guanylate cyclase, a nitric oxide receptor, is increased during the perinatal period.
Bloch KD; Filippov G; Sanchez LS; Nakane M; de la Monte SM
Am J Physiol; 1997 Mar; 272(3 Pt 1):L400-6. PubMed ID: 9124595
[TBL] [Abstract][Full Text] [Related]
31. Cyclic adenosine monophosphate (cAMP) increases natriuretic peptide receptor C (NPR-C) expression in human aortic smooth muscle cells.
Puggina E; Sellitti D
Mol Cell Endocrinol; 2004 Apr; 219(1-2):161-9. PubMed ID: 15149737
[TBL] [Abstract][Full Text] [Related]
32. Interleukin-1 beta and lipopolysaccharide decrease soluble guanylyl cyclase in brain cells: NO-independent destabilization of protein and NO-dependent decrease of mRNA.
Pedraza CE; Baltrons MA; Heneka MT; García A
J Neuroimmunol; 2003 Nov; 144(1-2):80-90. PubMed ID: 14597101
[TBL] [Abstract][Full Text] [Related]
33. PDE4 and PDE5 regulate cyclic nucleotides relaxing effects in human umbilical arteries.
Santos-Silva AJ; Cairrão E; Morgado M; Alvarez E; Verde I
Eur J Pharmacol; 2008 Mar; 582(1-3):102-9. PubMed ID: 18234184
[TBL] [Abstract][Full Text] [Related]
34. Role of phosphodiesterase 3 in NO/cGMP-mediated antiinflammatory effects in vascular smooth muscle cells.
Aizawa T; Wei H; Miano JM; Abe J; Berk BC; Yan C
Circ Res; 2003 Sep; 93(5):406-13. PubMed ID: 12919948
[TBL] [Abstract][Full Text] [Related]
35. Regulation of Sertoli cell tight junction dynamics in the rat testis via the nitric oxide synthase/soluble guanylate cyclase/3',5'-cyclic guanosine monophosphate/protein kinase G signaling pathway: an in vitro study.
Lee NP; Cheng CY
Endocrinology; 2003 Jul; 144(7):3114-29. PubMed ID: 12810568
[TBL] [Abstract][Full Text] [Related]
36. Activity and expression of soluble and particulate guanylate cyclases in myometrium from nonpregnant and pregnant women: down-regulation of soluble guanylate cyclase at term.
Telfer JF; Itoh H; Thomson AJ; Norman JE; Nakao K; Campa JS; Poston L; Tribe RM; Magness RR
J Clin Endocrinol Metab; 2001 Dec; 86(12):5934-43. PubMed ID: 11739467
[TBL] [Abstract][Full Text] [Related]
37. cAMP induces heme oxygenase-1 gene expression and carbon monoxide production in vascular smooth muscle.
Durante W; Christodoulides N; Cheng K; Peyton KJ; Sunahara RK; Schafer AI
Am J Physiol; 1997 Jul; 273(1 Pt 2):H317-23. PubMed ID: 9249506
[TBL] [Abstract][Full Text] [Related]
38. Arg-Gly-Asp (RGD)-containing peptides increase soluble guanylate cyclase in contractile cells.
Díez-Marqués ML; Ruiz-Torres MP; Griera M; López-Ongil S; Saura M; Rodríguez-Puyol D; Rodríguez-Puyol M
Cardiovasc Res; 2006 Feb; 69(2):359-69. PubMed ID: 16360131
[TBL] [Abstract][Full Text] [Related]
39. Desensitization of the soluble guanylyl cyclase/cGMP pathway by lipopolysaccharide in rat isolated pulmonary artery but not aorta.
El-Awady MS; Smirnov SV; Watson ML
Br J Pharmacol; 2008 Dec; 155(8):1164-73. PubMed ID: 18806822
[TBL] [Abstract][Full Text] [Related]
40. Protamine does not affect the formation of cGMP or cAMP in pig vascular smooth muscle cells in response to vasodilators.
Castresana MR; Zhang LM; Newman WH
Crit Care Med; 1995 May; 23(5):939-43. PubMed ID: 7736754
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
